These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18229459)

  • 1. Angiogenesis in portal hypertension: involvement in increased splanchnic blood flow and collaterals?
    Geerts AM; Colle I
    Acta Clin Belg; 2007; 62(5):271-5. PubMed ID: 18229459
    [No Abstract]   [Full Text] [Related]  

  • 2. NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.
    Angermayr B; Fernandez M; Mejias M; Gracia-Sancho J; Garcia-Pagan JC; Bosch J
    Gut; 2007 Apr; 56(4):560-4. PubMed ID: 16854998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
    Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
    Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of portal hypertension.
    Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC
    Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.
    Bosch J; Pizcueta MP; Fernández M; Feu F; Cirera I; Luca A; García-Pagán JC
    Baillieres Clin Gastroenterol; 1992 Sep; 6(3):425-36. PubMed ID: 1421593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin production in acute, chronic, and long-term experimental portal hypertension.
    Sitzmann JV; Campbell K; Wu Y; St Clair C
    Surgery; 1994 Mar; 115(3):290-4. PubMed ID: 8128353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular deterioration in cirrhosis: the big picture.
    Bosch J
    J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.
    Fernandez M; Mejias M; Garcia-Pras E; Mendez R; Garcia-Pagan JC; Bosch J
    Hepatology; 2007 Oct; 46(4):1208-17. PubMed ID: 17654489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension.
    Bosch J; Abraldes JG; Fernández M; García-Pagán JC
    J Hepatol; 2010 Sep; 53(3):558-67. PubMed ID: 20561700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
    Wiest R; Groszmann RJ
    Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Portal hypertension and angiogenesis].
    Stumm M; Sieber C
    Schweiz Med Wochenschr; 2000 Feb; 130(7):233-9. PubMed ID: 10719714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
    Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
    Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of placental growth factor in mesenteric neoangiogenesis in a mouse model of portal hypertension.
    Van Steenkiste C; Geerts A; Vanheule E; Van Vlierberghe H; De Vos F; Olievier K; Casteleyn C; Laukens D; De Vos M; Stassen JM; Carmeliet P; Colle I
    Gastroenterology; 2009 Dec; 137(6):2112-24.e1-6. PubMed ID: 19751735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal-systemic collaterals and angiogenesis.
    Chan CC
    J Chin Med Assoc; 2009 May; 72(5):223-4. PubMed ID: 19467943
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology of portal hypertension.
    Gupta TK; Chen L; Groszmann RJ
    Clin Liver Dis; 1997 May; 1(1):1-12. PubMed ID: 15562664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenic neurohormonal modulation of mesenteric vascular tone.
    Hamza SM; Kaufman S
    Exp Physiol; 2012 Sep; 97(9):1054-64. PubMed ID: 22198012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does local sympathetic atrophy contribute to splanchnic vasodilation in portal hypertension?
    Møller S; Stauber RE
    Liver Int; 2010 Apr; 30(4):499-501. PubMed ID: 20158609
    [No Abstract]   [Full Text] [Related]  

  • 20. [A clinical study on splanchnic hemodynamic changes after orthotopic liver transplantation for patients with portal hypertension].
    Jiang SM; Zhou GW; Shen C; Yan JQ; Wan L; Li QY; Yang WP; Shen BY; Chen H; Peng CH; Li HW
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1699-702. PubMed ID: 19094727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.